You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

List of Excipients in API guaifenesin extended-release

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing guaifenesin extended-release

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270	CARBOMER HOMOPOLYMER TYPE
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270	CELLULOSE, MICROCRYSTALLINE
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270	FD&C BLUE NO. 1
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270	HYPROMELLOSES
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270	MAGNESIUM STEARATE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for guaifenesin extended-release

Excipient focus: CARBOMER HOMOPOLYMER TYPE

guaifenesin extended-release drug variants containing CARBOMER HOMOPOLYMER TYPE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270
Granules India Ltd	guaifenesin extended-release	62207-697
>Company	>Ingredient	>NDC

guaifenesin extended-release drug variants not containing CARBOMER HOMOPOLYMER TYPE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE, MICROCRYSTALLINE

guaifenesin extended-release drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270
Granules India Ltd	guaifenesin extended-release	62207-697
>Company	>Ingredient	>NDC

guaifenesin extended-release drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C BLUE NO. 1

guaifenesin extended-release drug variants containing FD&C BLUE NO. 1

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270
Granules India Ltd	guaifenesin extended-release	62207-697
>Company	>Ingredient	>NDC

guaifenesin extended-release drug variants not containing FD&C BLUE NO. 1

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

guaifenesin extended-release drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270
Granules India Ltd	guaifenesin extended-release	62207-697
>Company	>Ingredient	>NDC

guaifenesin extended-release drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

guaifenesin extended-release drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270
Granules India Ltd	guaifenesin extended-release	62207-697
>Company	>Ingredient	>NDC

guaifenesin extended-release drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

guaifenesin extended-release drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Innovus Pharmaceuticals Inc	guaifenesin extended-release	57483-270
Granules India Ltd	guaifenesin extended-release	62207-697
>Company	>Ingredient	>NDC

guaifenesin extended-release drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.